Evidence map›Paper›PMID 41186804›Full record

ArticleJournal of computer-aided molecular design2025

Elucidating ligand recognition of reductive dehalogenases: the role of hydrophobic active site in organohalogen binding.

Yi Ren, Mike Manefield

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yi RenWater Research Centre, UNSW Sydney, Kensington, Australia.
Mike ManefieldWater Research Centre, UNSW Sydney, Kensington, Australia. manefield@unsw.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organohalide-respiring bacteria encoding reductive dehalogenases have shown substantial potential for bioremediation of organohalogen-contaminated environments. However, limited reactivity towards emerging pollutants, particularly fluorinated organics, constrains the broader application of these enzymes. To elucidate the molecular basis of this limitation, we investigated ligand-recognition mechanisms of the chlorinated-ethene dechlorinase PceA using molecular dynamics simulations. We find that tetrachlorinated ligands are stably accommodated in the binding pocket, whereas tetrafluorinated ligands can form hydrogen bonds with polar residues and are preferentially stabilised in a sub-pocket away from the catalytic site. Binding free-energy analyses indicate that van der Waals interactions and nonpolar solvation are the primary driving forces for association, favouring higher degrees of chlorination and longer carbon chains, and are facilitated by multiple aromatic residues. By contrast, polar solvation consistently opposes binding, with Arg305 acting as an antagonistic residue. Notably, polar solvation becomes more favourable with increasing fluorination for halogenated methanes and ethenes. The present study can provide insight for the relationship between binding free energy and ligands with various level of fluorination/chlorination and carbon chain length. The identified driving energy for ligand binding can be useful for understanding the limitations of reductive dehalogenase towards organofluorinated compounds.

Indexed as

Bacterial ProteinsHydrolasesOxidoreductasesBinding SitesCatalytic DomainHalogenationHydrogen BondingHydrophobic and Hydrophilic InteractionsLigandsMolecular Dynamics SimulationProtein BindingThermodynamicsBacterial ProteinsHydrolasesLigandsOxidoreductasestetrachloroethene dehalogenaseBinding free energyHydrophobic interactionLigand recognitionOrganofluorineReductive dehalogenase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.